Last reviewed · How we verify

NCT03430752

Comparing the Impact of Cancer on Quality of Life Between Survivors of Childhood Solid Tumors and Leukemia

Completed Last updated 28 June 2019
What this trial tests

trial testing questionnaires in Childhood Solid Tumor in 135 participants. Completed in 31 August 2018.

Timeline
5 September 2017
Primary endpoint
31 August 2018
31 August 2018

Quick facts

Lead sponsorThe University of Hong Kong
StatusCompleted
Study typeOBSERVATIONAL
Enrollment135
Start date5 September 2017
Primary completion31 August 2018
Estimated completion31 August 2018
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The University of Hong Kong

Who can join

Adults 6 to 19, any sex, with Childhood Solid Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to examine the impact of cancer and treatment-related effects on the physical and psychosocial well-being and quality of life among Hong Kong Chinese survivors of childhood solid tumors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of questionnaires

Trials testing the same drug.

Other The University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03430752.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing